Financial News Discussion of HGSI - Human Genome Sciences, Inc. on Countdown to the Closing Bell

Financial News for Human Genome Sciences, Inc. (HGSI)

HGSI 3/19/2010 4:00PM 52 Week Price Range Market Capitalization Dividend Yield Recent Dividend
$30.76 $0.75 — $33.13 $5.7 Billion n/a n/a

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Sign Up Now for Ockham's Stock Analysis and News Services

Explore Why Ockham?

Quality Analysis
Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)
Crowd Sentiment
Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)
Financial News Slicing
With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)
Human Genome Sciences, Inc. was discussed on Countdown to the Closing Bell which was originally produced by Fox Business on 11/2/2009
Viewers on 11/2/09 heard about Human Genome Sciences, Inc. on Countdown to the Closing Bell with host, Liz Claman. It is always interesting to see how discussions of Human Genome Sciences, Inc. affect the stock going forward.

Human Genome Sciences, Inc. is in the news. Find out how this impacts HGSI trading on Ockham Research.

To a year ago, not good for stock. >> intel, I remind you was a $12 stock. They have come fighting back. Shibani? >> I know you're speaking to the HUMAN GENOME SCIENCES ceo but it's not HUMAN GENOME SCIENCES active. You're hot or not in the there are big-time swings in you got to talk about the the company, fda response for its bone drug and obviously the news is not good. >> shibani, thank you for putting spin on that. Lupus sufferers, let's get to this, may have new hope.

“time swings in you got to talk about the the company, fda response for its bone drug and obviously the news is not good.
shibani, thank you for putting spin on that. Lupus sufferers, let's get to this, may have new hope. ”
Countdown to the Closing Bell Nov 2, 2009 3:37 PM
Since it's appearance on Countdown to the Closing Bell: